Top

Published in:

Open Access 01-12-2011 | Oral presentation

Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX

Authors: M Verkaaik, M Bulatović, G Sinnema, C Rademaker, NM Wulffraat

Published in: Pediatric Rheumatology | Special Issue 1/2011

Excerpt

More than 50% of JIA patients on Methotrexate (MTX) suffer from MTX-related gastrointestinal adverse effects – MTX intolerance (1). Nevertheless, the best approach to treat MTX intolerance is unknown. …

Bulatovic M, Heijstek MW, Verkaaik M, van Dijkhuizen EH, Armbrust W, Hoppenreijs EP: High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: Development and validation of a methotrexate intolerance severity score. Arthritis Rheum. 2011, Epub ahead of print

Title: Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX
Authors: M Verkaaik
M Bulatović
G Sinnema
C Rademaker
NM Wulffraat
Publication date: 01-12-2011
Publisher: BioMed Central
Published in: Pediatric Rheumatology / Issue Special Issue 1/2011
Electronic ISSN: 1546-0096
DOI: https://doi.org/10.1186/1546-0096-9-S1-O23

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2011

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic

Imunological and clinical characteristics in children with polyarteritis nodosa: a retrospective study over the last 20 years

Quality of life in patients with juvenile arthritis: adalimumab might make a difference

Hyper-IgD syndrome: a new mutation (p.R277G) with a severe phenotype

Chronic nonbacterial osteomyelitis in children

Evidence for association of autoimmune genes with disabilty in juvenile idiopathic arthritis in a UK cohort